Instead Of VC, Try Philanthropy: Inside Medical Research Charity LifeArc

Having already made a substantial contribution to the life sciences field with its work humanizing blockbuster anti-cancer antibody Keytruda, UK-based medical research charity LifeArc has committed itself to spend millions through to the end of the decade funding promising early-stage translational research. In Vivo reporter Chloe Kent spoke with LifeArc CEO Melanie Lee to find out more about the operational differences between charitable donation and venture capital in biopharma funding, how the organization assesses its impact and Lee’s experience as a woman in life sciences.

Time